An interventional study of Interdisciplinary care + booster session (intervention) and Interdisciplinary care (control) in Chronic Pain and Pain Management, sponsored by Vastra Gotaland Region. Active, not recruiting at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-20.
Sponsored by Vastra Gotaland Region · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 88 studies in Chronic Pain with a site in Sweden — 30 open to participants now, 37 under way, none of them phase 3. Chronic Pain · Sweden.
Among the 88 studies in Chronic Pain with a site in Sweden, this one is the 10th largest by planned enrollment of the 65 interventional ones that give a count, is one of 3 that started in 2023, is one of 61 with no phase, reaches primary completion later than 13 of the 36 other live ones, and was the 62nd registered.
3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.
Browse Chronic Pain studies →30 of the 88 studies in Chronic Pain with a site in Sweden are open now. Recruiting first, the newest first:
Skane University Hospital · Sites in Sweden
Ages 15–24
Karolinska Institutet · Sites in Sweden
Ages 18+
Skane University Hospital · Sites in Sweden
Ages 18–65
Catholic University of the Sacred Heart · Sites in Sweden, Italy
Ages 18+
Lund University · Sites in Sweden
Ages 18+
A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →
Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
88 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 1 · Phase 3 1 · Phase 4 1
First in 2004; this study’s year is marked. 3 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 200 is above the median of 60 across 2,388 interventional studies indexed under Chronic Pain.
Median enrollment 80 across the 65 interventional studies, 144 across the 23 observational. Of the 44 that completed or were terminated, 3 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 88 have an industry lead sponsor. The 10 most frequent:
Vastra Gotaland Region is the lead sponsor of 276 studies on the registry; 110 are open to participants now.
Vastra Gotaland Region has 4 studies filed under Chronic Pain — fewer than ten, so there is no comparison to draw.
11 of the studies in Chronic Pain with a site in Sweden that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06410963Örebro University, SwedenReActivate: Physiotherapist Led Intervention for A Adolescents and Young Adults With Musculoskelatal Pain | 2026-11-30 |
| NCT06981312Region StockholmInternet-Delivered Psychological Treatments for Chronic Pain in Adolescents: ACT and Pain Education. | 2026-12 |
| NCT06084390Vastra Gotaland RegionInterdisciplinary Rehabilitation for Chronic Pain in Primary Healthcare | 2026-12-31 |
| NCT06981611Karlstad UniversityVulvodynia Intervention: the Effect of Multimodal Treatment for Provoked Vulvodynia | 2026-12-31 |
| NCT07092332Region Örebro CountyYoung Vulvodynia: Effect and Efficacy of Multimodal Treatment. | 2026-12-31 |
Add all 11 to your calendar (.ics) → With an account.
Among the 88 studies in Chronic Pain with a site in Sweden, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Purpose: The overall aim is to investigate the effect of interdisciplinary rehabilitation in primary health care (PHC) for patients with chronic pain. Specific questions: What is the effect of extended access to the interdisciplinary PHC pain team + a booster session after finishing the rehabilitation program? Does participation in PHC interdisciplinary rehabilitation contribute to health improvements and are there predictors of this? Method: A randomized controlled trial (RCT). 200 patients with chronic pain that participate in interdisciplinary rehabilitation in primary healthcare in Region Västra Götaland (VGR) in Sweden will be included in the RCT and randomized to Intervention; standard care by the interdisciplinary teams in PHC + extended access to the team and a booster session 3 months after the end of the rehabilitation, or Control; only standard care by the interdisciplinary teams. Outcomes are health related quality of life, pain intensity and other health aspects.
The participants will be randomly allocated to intervention or active control. All participants in both arms receive the standard care for interdisciplinary rehabilitation at any of the six PHC pain teams in VGR. The teams consist of a physician, physiotherapist, occupational therapist and psychologist. All teams provide person-centred rehabilitation, aiming to increase physical activity and support behavioural changes, and to decrease symptoms and the impact of pain on the patients´ daily lives. The standard care interdisciplinary rehabilitation period contains both theoretical and practical components such as patient education, physical exercise and behavioural interventions. The sessions are mainly group-based. The duration of the rehabilitation period varies between 5 to 7 weeks + a follow-up visit after 3 months.
The participants in the intervention arm also receive an extra booster-session 3 months after the standard follow-up. At the booster-session, the participant´s individual rehabilitation plan is followed-up and adjusted. This extra period also includes extended access to the team, meaning that the participants have the possibility to contact the team and, if needed, have digital or telephone contact.
The participants complete a battery of questionaires included in the Swedish Quality Registry for Pain Rehabilitation an also extra questionnaires provided to the participants through an electronic research form.
Data collection is made at baseline before starting the rehabilitation, directly after the 5 to 7 weeks rehabilitation period and 6, 12 and 24 months after baseline.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Standard care by the interdisciplinary rehabilitation teams in primary healthcare + extended access to the team and a booster visit after 3 months.
Other: Interdisciplinary care + booster session (intervention)
Standard care by the interdisciplinary rehabilitation teams in primary healthcare.
Other: Interdisciplinary care (control)
Standard care for interdisciplinary rehabilitation at any of the six interdisciplinary teams in primary health care in Region Västra Götaland, Sweden + one extra booster-session 3 months after the standard care rehabilitation. At the booster-session, the participant´s individual rehabilitation plan is followed-up and adjusted. This extra period also includes extended access to the team, meaning that the participants have the possibility to contact the team and, if needed, have digital or telephone contact.
Standard care for interdisciplinary rehabilitation at any of the six interdisciplinary teams in primary health care in Region Västra Götaland, Sweden.
Pain intensity
Assessed with visual analog scale and numeric rating scale (0-100 mm, higher is more severe pain)
Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.
Health related quality of life
Rand-36 (0-100, a higher score indicates better health-related quality of life)
Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.
Health related quality of life 2
EuroQol 5D-3L (0-100, a higher score indicates better health-related quality of life)
Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.
Health related quality of life 3
EuroQol-Visual analogue scale (0-100, a higher score indicates better health-related quality of life)
Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.
Pain spread
The participants mark in boxes painful areas
Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.
Pain acceptance
The Chronic pain acceptance questionnaire (CPAQ-8) (Total score 0-48, 2 subscales 0-24 p. Higher score means better pain acceptance)
Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.
Self-efficacy
The Pain self-efficacy questionnaire short-form (PSEQ\_2) (0-12, a higher score means better self-efficacy)
Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from from the end of the rehabilitation period.
Symptoms of stress
The stress and crisis inventory (SCI-93) (0-140, a higher score means more stress) symptoms)
Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.
Physical activity
The Godin questionnaire (hours of physical activity per week)
Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.
Anxiety and depression
The hospital anxiety and depression scale (2 subscales for symptoms of anxiety and depression ranging from 0 to 21, a higher value means a higher degree of anxiety or depression)
Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.
Self-rated function
The Functional rating index (0-100 %, higher percent is worse)
Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.
Work ability
One question (number 7) from the Work ability index (0-10, higher score is better)
Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.
Life satisfaction
The LiSat questionnaire (2 questions ranging 1-6, higher score is better life satisfaction)
Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.
Fatigue
The multidimensional fatigue inventory (5 subscales ranging from 4 -20, higher score means more fatigue)
Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.
Pain catastrophizing
The pain catastrophizing scale (Total score 0-52, higher score is worse)
Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.
Patients´ own impression of change
Patient global impression of change (1-7, lower score means more improvement)
Time frame: Directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.
Health care use
Health care visit statistics
Time frame: From 12 months before to 24 months after the rehabilitation period.
Sickness abscence
Sickness absence data
Time frame: From 12 months before to 24 months after the rehabilitation period.
Plan to share: No
No publications or documents are linked to this record.
Started Oct 2023 (actual). Primary completion is estimated for Dec 2026, 38 months after the start.
Of 1,297 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's planned 38 months is above that.
Counting every sponsor, half of 1,380 studies reached it within 20 months; a quarter within 9 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.